Rocuronium Fresenius rocuronium bromide 50mg/5mL solution for injection vial

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

rocuronium bromide, Quantity: 10 g/L

Commercializzato da:

Fresenius Kabi Australia Pty Ltd

INN (Nome Internazionale):

Rocuronium bromide

Forma farmaceutica:

Injection, solution

Composizione:

Excipient Ingredients: water for injections; glacial acetic acid; sodium acetate trihydrate; sodium chloride

Via di somministrazione:

Intravenous

Confezione:

10 x 5mL, 5 x 5mL

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

INDICATIONS,Rocuronium is indicated as an adjunct to general anaesthesia to facilitate endotracheal intubation during routine induction, to provide muscle relaxation and to facilitate mechanical ventilation in adults, children and infants over 1 month of age.,Rocuronium is also indicated as an adjunct to general anaesthesia to facilitate endotracheal intubation during rapid sequence induction when suxamethonium is contraindicated, however, this has not been studied in infants and children.,Rocuronium is also indicated as an adjunct in the intensive care unit (ICU) to facilitate mechanical ventilation.

Dettagli prodotto:

Visual Identification: A clear, colourless to pale brownish-yellow solution.; Container Type: Vial; Container Material: Glass; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2014-11-12